The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.26913 ↗At a glance
Übersichtsarbeit in Pediatric Pulmonology, 2024. Written by Nicole Green and 2 co-authors. Institution: Department of Pediatrics, Division of Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, Washington, US…. Major MEDLINE topics: Cystic Fibrosis, Gastrointestinal Microbiome, Probiotics, Dysbiosis. Cited 7 times so far (Crossref); 125 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council (NHMRC, Australia) Investigator.
Abstract (original language)
People with cystic fibrosis (pwCF) have an altered gastrointestinal microbiome. These individuals also demonstrate propensity toward developing small intestinal bacterial overgrowth (SIBO). The dysbiosis present has intestinal and extraintestinal implications, including potential links with the higher rates of gastrointestinal malignancies described in CF. Given these implications, there is growing interest in therapeutic options for microbiome modulation. Alternative therapies, including probiotics and prebiotics, and current CF transmembrane conductance regulator gene modulators are promising interventions for ameliorating gut microbiome dysfunction in pwCF. This article will characterize and discuss the current state of knowledge and expert opinions on gut dysbiosis and SIBO in the context of CF, before reviewing the current evidence supporting gut microbial modulating therapies in CF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatrics, Division of Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
- Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Gastroenterology, Sydney Children's Hospital, Randwick, New South Wales, Australia.
ORCID profiles: Nicole Green, Christopher Chan
Funding
- National Health and Medical Research Council (NHMRC, Australia) Investigator
Cite
APA
Green, N., Chan, C., & Ooi, C. Y. (2024). The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26913
Vancouver
Green N, Chan C, Ooi CY. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26913
BibTeX
@article{Green2024,
author = {Green, Nicole and Chan, Christopher and Ooi, Chee Y},
title = {The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.26913}
}
EUVIMED